FUS and amyotrophic lateral sclerosis: Recognized pathological hallmarks of ALS include the nuclear-to-cytoplasmic redistribution of RNA binding proteins (RBPs), including TAR DNA binding protein of 43 kDa (TDP-43), fused in sarcoma (FUS), and splicing factor proline- and glutamine-rich (SFPQ) (1–5).